Coronavirus vaccine breakthrough: Pfizer trial with 95% success – authorisation in days

We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights.

Last week the company, that works in partnership with BioNTech, published interim results showing the vaccine could prevent more than 90 percent of people developing COVID-19. But the latest trial shows the jab is now 95 percent effective. 

Pfizer said the final results from its latest trial mean it has reached the required two-months of safety data.

The company will apply for emergency US authorisation of the drug in the coming days.

More to follow….

Source: Read Full Article